PTX3 and coronary artery disorder: Moreover, the meta-analysis of 15 studies, including 11,365 participants with coronary artery disease, showed that the adjusted odds ratios for composite poor outcomes increased by 32% per 1 ng/mL PTX-3 increment [19].